Treatment of choice in intracran al ALL is:
High-Yield Explanation
Answer is A (Intrathecal methotrexate) Intrathecal ,methotrexate is the chemotherapy of choice for intracranial manifestation of Acute Leukemia Treatment of choice for intracranial ALL Combination of intrathecal methotrexate and cranial irradiation. Agents used for Intrathecal chemotherapy Methotrexate Cytarabine Thiotepa Note: Intrathecal Cytarabine may be as effective as intrathecal methotrexate